Torrent Pharmaceuticals Ltd., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 43189.02 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-12-2020, the company reported a Consolidated Total Income of Rs 2003.00 Crore, down -.99 % from last quarter Total Income of Rs 2023.00 Crore and down -.79 % from last year same quarter Total Income of Rs 2019.00 Crore. Company reported net profit after tax of Rs 297.00 Crore in latest quarter.
Investment Rationale
Revenues are expected to grow 2.3% YoY to Rs 1990 crore with domestic sales growing 8% YoY to Rs 907 crore mostly offset by continued decline in US sales to Rs 279 crore (down 28% YoY). EBITDA margins are expected to improve 134 bps to 29.5% due to lower marketing and travel spend. However, net profit is expected to decline 13.4% YoY to Rs 272 crore due to negative tax rate in base year
Promoter/FII Holdings
Promoters held 71.3 per cent stake in the company as of Sept 30, 2020, while FIIs held 12.2 per cent, DIIs 8.4 per cent and public and others 8.1 per cent.
